Meet the Team...
Our success at Taran Therapeutics is a reflection of the hard work and commitment of our skilled team. We believe in harnessing diverse expertise to develop groundbreaking medical solutions. Get to know the professionals whose passion fuels our mission to enhance patient care and treatment outcomes.
Founder, CEO
Dr. Durrant is the founder of Taran Therapeutics and brings experience as a senior leader at several global pharmaceuticals companies, extensive end-to-end product development, launch and commercialization expertise, including 5 global blockbusters. He has significant biotech, operating executive as CEO, interim CFO, CMO and board member of both public and private companies.
Dr. Durrant has developed a deep understanding of lenzilumab and ifabotuzumab, having worked on these product for 10 years, first as Chairman and CEO of Humanigen from January 2016 and then later acquiring these products under Taran.
He earned his medical degree from the Welsh National School of Medicine, Cardiff, UK and various post-graduate medical diplomas and memberships in the UK and his MBA from Henley Management College, Oxford. He was a regional Entrepreneur of the Year, a Fellow of the Learned Society of Wales and a Professor at the Cardiff University School of Medicine.
He has authored or co-authored papers which have appeared in peer-reviewed medical journals and is the owner or inventor of dozens of patents.
Board Member
Michael Schuster Co-Founded Mesoblast Limited and Angioblast Systems Inc. in 2004. He was part of the executive management team at both companies and currently serves as the head of pharma partnering and project management at Mesoblast Limited and was previously the head of the company's investor relations outreach program.
Mr. Schuster was Executive Vice President of Global Therapeutic Programs from 2010 to 2013 and was the Director of Business Development and Vice President of Operations from 2004 to 2010.
He holds an undergraduate degree in science from Tufts University, a Master's degree in Immunology & Microbiology from New York Medical College, and an MBA from Fordham University in New York.
